News - AstraZeneca, GlaxoSmithKline


Popular Filters

Seven pharma companies offer up compounds to UK researchers

Seven pharma companies offer up compounds to UK researchers


UK researchers will be granted access to a ‘virtual library’ of deprioritized pharmaceutical compounds…

AstraZenecaEli LillyGlaxoSmithKlineJanssenMedical Research CouncilPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

Pharma multinationals facing more pricing problems in India

Pharma multinationals facing more pricing problems in India


Even as a battle royal appears to be brewing between India's drug price regulator, the National Pharma…


Report: Health care companies lead the way in corporate compliance


Health care companies are leading the way in terms of public trust and transparency, according to The…

AstraZenecaGlaxoSmithKlineLegalManagementPharmaceuticalReckitt BenckiserUK

Morningstar analysts find GlaxoSmithKline has strongest pipeline

Morningstar analysts find GlaxoSmithKline has strongest pipeline


Morningstar, an independent Chicago-based investment research firm, recently published the November 2013…

AbbVieAstraZenecaBayerFinancialGlaxoSmithKlineMerck & CoPharmaceuticalResearchSanofi

Generic risk to GSK's Advair prompts buy recommendation from analysts


Pharmaceutical analysts are urging investors to buy shares of UK pharma major GlaxoSmithKline (LSE: GSK)…

AdvairAstraZenecaBoehringer IngelheimEuropeFinancialGlaxoSmithKlinePharmaceuticalRespiratory and PulmonarySandozSpirivaSymbicort

Research briefs: Lilly's Forteo; Genmab/GSK's Arzerra; AstraZeneca's Symbicort


US drug major Eli Lilly (NYSE: LLY) has reported new data demonstrating that Forteo (teriparatide) significantly…

Anti-Arthritics/RheumaticsArzerraAstraZenecaEli LillyForteoGenmabGlaxoSmithKlineOncologyPharmaceuticalResearchRespiratory and PulmonarySymbicort

Flu vaccine innovation needed to protect children, says GlobalData health care expert


The last time the USA confronted a flu season this early, the virus claimed the lives of nearly 50,000…


Big Pharma doing more for access to medicine in developing countries than two years ago


The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts…

AstraZenecaBayerGlaxoSmithKlineGlobalHealthcareJohnson & JohnsonMerck KGaAPharmaceuticalPricingResearch

Asthma preventive drugs market led by GlaxoSmithKline's Advair


The asthma preventive drugs market has been forecast to increase at a compound annual growth rate (CAGR)…

AdvairAstraZenecaGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicort

Pharma partnering dollars continue to decline, Burrill & Co reports


The recent $3.4 billion partnering agreement announced in July between US pharma company Bristol-Myers…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbFinancialGlaxoSmithKlineHuman Genome SciencesLicensingMarkets & Marketing

UK academia-pharma collaboration attracts £14.4 million funding


In the UK, the University of Dundee and the Medical Research Council (MRC) have announced new funding…

AstraZenecaBoehringer IngelheimEuropeFinancialGlaxoSmithKlineJohnson & JohnsonMerck SeronoPfizerPharmaceuticalResearch

Nine news Rx drugs added to Australian PBS listings


Australia’s Federal Minister for Health, Tanya Plibersek, yesterday announced the listing of nine…


EU Pharma re-rating stalled against EU market vis-a-vis defensives, says Nomura analyst


While European Union Pharma has outperformed the EU market by 16% year-to-date, the corresponding performance…


Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top